Answers are grounded in this paper and cite their sources.
Telomeres are essential for maintaining linear chromosome integrity, making their dysregulation in cancer an attractive target for DNA damage–mediated therapeutic interventions. Here, we explored the effects of targeting telomeric repeat sequences with CRISPR-Cas9 in human cells. At high expression levels achieved through transient transfection, telomere-specific CRISPR-Cas9 (TelCR), one of two possible telomere-targeting CRISPR-Cas9 constructs, triggered acute telomere loss, activated the ATR–CHK1/2–WEE1 G 2 DNA damage checkpoint, and promoted apoptosis in HeLa cells. Conversely, an inducible system delivering sublethal levels of TelCR resulted in progressive telomere attrition and an ATM-dependent DNA damage response. TelCR also induced chromosomal instability, characterized by the formation of multicentric chromosomes. Moreover, sublethal telomeric damage elicited a transcriptional program distinct from nonspecific DNA breaks, characterized by enrichment of pathways associated with metabolic adaptation, stress responses, and innate immune signaling. Collectively, these findings reveal distinct cellular and transcriptional responses to telomere-specific CRISPR-Cas9–mediated damage, highlighting its utility as a tool for inducing targeted telomeric damage.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: